HCA Healthcare, Inc. reported a significant increase in financial performance for the third quarter of 2025, with revenues rising to $19.161 billion, up 9.6% from $17.487 billion in the same quarter of 2024. The company's net income attributable to HCA Healthcare, Inc. reached $1.643 billion, or $6.96 per diluted share, compared to $1.270 billion, or $4.88 per diluted share, in the prior year. This growth in profitability was bolstered by a 6.1% increase in revenue per equivalent admission and a 3.2% rise in equivalent admissions, reflecting a positive trend in patient volume and service utilization.
In the nine months ending September 30, 2025, HCA Healthcare's revenues also saw a 7.2% increase, totaling $56.087 billion compared to $52.318 billion in the same period of 2024. Net income for this period was $4.906 billion, or $20.23 per diluted share, up from $4.322 billion, or $16.37 per diluted share, in the previous year. The company attributed these results to improved operational efficiencies and a favorable payer mix, particularly in state supplemental Medicaid revenue.
Operationally, HCA Healthcare reported a 2.8% increase in consolidated admissions and a 2.0% increase in inpatient surgical volumes for the third quarter of 2025 compared to the same quarter in 2024. Emergency department visits also rose by 1.2%. The company operated 191 hospitals and 123 freestanding outpatient surgical centers as of September 30, 2025, with a total of 50,577 licensed hospital beds. The company’s focus on enhancing patient care and operational efficiency has contributed to these positive metrics.
Strategically, HCA Healthcare has continued to expand its footprint, acquiring two hospital facilities in New Hampshire and Florida for $190 million and investing $171 million in non-hospital healthcare entities during the first nine months of 2025. The company also reported cash flows from operating activities of $10.277 billion for the first nine months of 2025, a substantial increase from $7.955 billion in the same period of 2024. This increase was primarily driven by higher net income and a reduction in income taxes paid due to an IRS deferral.
Looking ahead, HCA Healthcare is closely monitoring various healthcare policy changes, including the implications of the One Big Beautiful Bill Act, which may affect Medicaid funding and reimbursement rates. The company is also preparing for potential impacts from a federal government shutdown that began on October 1, 2025. Despite these challenges, HCA Healthcare remains committed to its growth strategy and anticipates continued operational improvements and financial stability in the coming quarters.
About HCA Healthcare, Inc.
HCA Healthcare, Inc. is a leading U.S. health care services company operating hospitals, outpatient centers, and behavioral facilities. It provides comprehensive medical, surgical, mental health, and outpatient services across multiple states and England. The company focuses on delivering high-quality, cost-effective care, leveraging extensive networks, operational excellence, and strategic growth in inpatient, outpatient, and specialty care markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.